Retained Earnings
Revolution Medicines, Inc. Retained Earnings decreased by 15.8% to -$3.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 70.3%, from -$1.95B to -$3.32B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows a downward trend with a 61.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
Detailed definition
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
Peer comparison
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$347.02M | -$399.96M | -$452.64M | -$510.28M | -$571.51M | -$644.83M | -$701.34M | -$769.44M | -$867.74M | -$976.17M | -$1.14B | -$1.25B | -$1.39B | -$1.54B | -$1.74B | -$1.95B | -$2.20B | -$2.50B | -$2.87B | -$3.32B |
| QoQ Change | — | -15.3% | -13.2% | -12.7% | -12.0% | -12.8% | -8.8% | -9.7% | -12.8% | -12.5% | -16.5% | -10.2% | -10.6% | -11.3% | -12.6% | -12.3% | -12.7% | -13.9% | -14.6% | -15.8% |
| YoY Change | — | — | — | — | -64.7% | -61.2% | -54.9% | -50.8% | -51.8% | -51.4% | -62.2% | -62.9% | -59.8% | -58.1% | -52.7% | -55.6% | -58.6% | -62.3% | -65.1% | -70.3% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s retained earnings?
- Revolution Medicines, Inc. (RVMD) reported retained earnings of -$3.32B in Q1 2026.
- How has Revolution Medicines, Inc.'s retained earnings changed year-over-year?
- Revolution Medicines, Inc.'s retained earnings decreased by 70.3% year-over-year, from -$1.95B to -$3.32B.
- What is the long-term trend for Revolution Medicines, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s retained earnings has grown at a 61.0% compound annual growth rate (CAGR), from -$265.55M to -$2.87B.
- What does retained earnings mean?
- The total accumulated profits the company has kept and reinvested rather than paying out as dividends.